TABLE 46 NUMBER OF PEOPLE IN THE U.S. LIVING WITH A FUNCTIONING TRANSPLANT BY TYPE, 2000-2005* 109
Organ Substitutes 109
Organs from Animals: Xenotransplantation 109
Organ Primordia 110
Nuclear Transfer to Eliminate the Rejection Gene 110
Porcine Endogenous Retrovirus 111
ARTIFICIAL ORGANS 111
CELLULAR TRANSPLANTS 112
ORGAN REJECTION STRATEGIES 112
KEY FACTORS INHIBITING GROWTH 113
LACK OF DONORS 113
ALTERNATIVE THERAPIES 113
CULTURAL STIGMAS 113
Chapter-6: DISABLED AND ELDERLY ASSISTIVE TECHNOLOGIES IN THE U.S.
INTRODUCTION 114
ASSISTIVE TECHNOLOGY PRODUCTS 114
STUDY BACKGROUND 114
STUDY GOALS AND OBJECTIVES 115
INTENDED AUDIENCE 115
SCOPE OF REPORT 116
METHODOLOGY AND INFORMATION SOURCES 117
ANALYST CREDENTIALS 117
RELATED BCC RESEARCH REPORTS 117
SUMMARY 118
TABLE 47 PROJECTED U.S. ASSISTIVE TECHNOLOGY SALES, THROUGH 2013 ($ MILLIONS) 118
FIGURE 12 PROJECTED U.S. ASSISTIVE TECHNOLOGY SALES, 2007-2013 ($ MILLIONS) 119
INDUSTRY STRUCTURE AND COMPETITION 119
NUMBER AND SIZE OF FIRMS 119
MARKET SHARES 120
Mobility Aids 120
FIGURE 13 MOBILITY AIDS MARKET LEADERS, 2007 (%) 121
Access Aids 121
FIGURE 14 ACCESS AIDS MARKET LEADERS, 2007 (%) 122
Beds, Seating Systems, and Ergonomic Aids 122
FIGURE 15 BEDS, SEATING SYSTEMS, AND ERGONOMETRIC AIDS MARKET LEADERS, 2007 (%) 123
Daily Living Aids 123
FIGURE 16 DAILY LIVING
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |